Prospect Medical Holdings, Inc. (PZZ)
F2Q10 (Qtr End 03/31/10) Earnings Call Transcript
May 18, 2010 4:15 pm ET
Devin Sullivan – IR, The Equity Group Inc.
Sam Lee – Chairman and CEO
Mike Heather – CFO
Kyle Smith – Jefferies & Company
Miles Highsmith – RBC Capital Markets
Jacques Cornet – Gates Capital
Good day everyone and welcome to the Prospect Medical Holdings second quarter financial results call. At this time, I would like to inform you that this conference is being recorded and that all participants are currently in a listen-only mode. I will now turn the conference over to Devin Sullivan. Please go ahead sir.
Thank you, Michael, and good afternoon everyone. Thank you for joining us today for Prospect Medical Holdings’s second quarter financial results conference call. Our speakers today will be Sam Lee, Chairman and CEO of Prospect Medical Holdings; and Mike Heather, Chief Financial Officer. Also on the call is Adam Goldston, Prospect’s Senior Vice President. Before turning things over to Mr. Lee, I would like to remind everyone that statements made during today’s call may contain forward-looking statements which are not historical facts.
Investors are cautioned that forward-looking statements including statements regarding anticipated or expected results involve risks and uncertainties which may affect the company’s business and prospects including those outlined in prospects Form 10-Q, which was filed on May 17, 2010, and other filings.
Any forward-looking statements discussed during this call represent management’s estimates only as of the date hereof or as of such earlier dates as are indicated and should not be relied upon as representing estimates as of any subsequent date. While Prospect may elect to update forward-looking statements at some point in the future, the company specifically disclaims any obligation to do so even if its estimates change.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts